Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2)
Clinical trial NCT03816839 · TERMINATED
Trial details
- NCT number
- NCT03816839
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-25
- Primary completion
- 2020-10-27
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.